Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 139
Filter
1.
Rev. argent. cir ; 112(1): 9-15, mar. 2020. graf, tab
Article in English, Spanish | LILACS | ID: biblio-1125776

ABSTRACT

Antecedentes: la hipocalcemia es la complicación más frecuente luego de una tiroidectomía total y puede manifestarse de manera bioquímica, o con síntomas leves o severos. Objetivos: analizar factores de riesgo asociados al desarrollo de hipocalcemia severa postiroidectomía total. Material y métodos: se incluyeron pacientes en los que se realizó tiroidectomía total primaria, analizando factores de riesgo asociados al desarrollo de hipocalcemia severa (signos y síntomas que requirieron internación y tratamiento con calcio intravenoso o persistencia de signosintomatología luego de 48 horas de haber recibido tratamiento inicial vía oral). Se analizaron variables demográficas, clínico-quirúrgicas e histopatológicas. Resultados: se realizaron un total de 1665 tiroidectomías entre 2007 y 2018 y, de estas, 918 fueron tiroidectomías totales primarias. Un total de 203 (22%) pacientes desarrollaron hipocalcemia. De ellos, 183 (20%) presentaron hipocalcemia leve y 20 (2%) hipocalcemia severa. En el análisis univariado, la edad, la intervención por cirujano especialista en cabeza y cuello, el peso de la glándula tiroides mayor de 30 gramos, la resección paratiroidea y la patología maligna se vieron asociados al desarrollo de hipocalcemia severa. En el análisis multivariado, los últimos tres fueron factores de riesgo asociados a esta complicación, con significancia estadística. Conclusiones: en nuestra serie, los factores de riesgo asociados al desarrollo de hipocalcemia severa postiroidectomía total fueron la resección, advertida o inadvertida de las glándulas paratiroides, el peso de la glándula tiroides mayor de 30 gramos y la patología maligna. Por lo tanto, en estos pacientes debemos prestar especial atención al desarrollo de dicha complicación en el posoperatorio.


Background: Hypocalcemia is the most common complication after a total thyroidectomy. It may occur as biochemical hypocalcemia, or with mild or severe symptoms. Objectives: The aim of this study was to analyze the risk factors associated with the development of severe hypocalcemia after total thyroidectomy. Material and methods: Patients undergoing primary total thyroidectomy were included. The risk factors for the development of severe hypocalcemia (signs and symptoms requiring hospitalization and treatment with intravenous calcium or persistence of signs and symptoms after 48 hours of initial oral treatment) were analyzed. The evaluation included analysis of the demographic, clinical, surgical and histopathological variables. Results: Of 1665 thyroid resections performed between 2007 and 2018, 918 corresponded to primary total thyroidectomies; 203 (22%) of these patients developed hypocalcemia. Mild hypocalcemia occurred in 183 (20%) cases and sever hypocalcemia in 20 (2%) patients, The univariate analysis showed that a procedure performed by head and neck surgeons, thyroid gland weight > 30 g, resection of the parathyroid glands and thyroid cancer were associated with the development of severe hypocalcemia. On multivariate analysis, the last three variables were risk factors significantly associated with this complication. Conclusions: In our series, noticed or inadvertent resection of the parathyroid glands with subsequent reimplantation, high weight of the thyroid gland and malignancy were identified as risk factors for the development of severe hypocalcemia after total thyroidectomy. Therefore, we should pay special attention to the development of such complication in the postoperative period.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Thyroidectomy/adverse effects , Risk Factors , Hypocalcemia/pathology , Postoperative Complications/drug therapy , Calcium , Prospective Studies , Retrospective Studies , Clinical Laboratory Techniques/methods
2.
Medicina (B.Aires) ; 79(6): 483-492, dic. 2019. ilus, tab
Article in Spanish | LILACS | ID: biblio-1056757

ABSTRACT

Las infecciones asociadas a procedimientos neuroquiró;ºrgicos son complicaciones graves que contribuyen a la morbimortalidad de los pacientes neurocríticos, así como tambín a la prolongació;n de la estancia en la UTI y/o en el hospital. El diagnó;stico es complejo ya que no se dispone de gold standard y se apoya en la sospecha clínica, las alteraciones físico-químicas del líquido cefalorraquídeo y el aislamiento microbiano. El tratamiento debe ser precoz y guiado por la epidemiología local. La duració;n dependerá del microorganismo causal, su sensibilidad y la disponibilidad de tratamientos antibió;ticos efectivos en el sitio de la infecció;n. La implementació;n de medidas de prevenció;n con evidencia demostrada minimiza el riesgo de infecció;n. Esta puesta al día intersociedades SADI-SATI presenta datos epidemioló;gicos (internacionales y locales), mó;©todos diagnó;sticos, tratamiento, y pautas de prevenció;n, considerando las publicaciones más relevantes de los ó;ºltimos aó;±os sobre el tema.


Infections associated with neurosurgical procedures are serious complications that contribute to the morbidity and mortality of neurocritical patients, as well as to the prolongation of the stay in the ICU and the hospital. The diagnosis is complex since there is no gold standard, so it is based on clinical suspicion, CSF physical-chemical examination, and microbial isolation. Treatment should be initiated early, guided by local epidemiology. The duration will depend on the causative microorganism, its sensitivity and the availability of antibiotic treatments that are effective at the site of infection. The implementation of preventive measures with proven efficacy minimizes the risk of infection. This SADI-SATI intersociety update reviews relevant data recently published on this area at the national at international level regarding epidemiology, diagnostic methodologies, therapeutic approaches, and prevention guidelines.


Subject(s)
Humans , Postoperative Complications/etiology , Meningitis, Bacterial/etiology , Practice Guidelines as Topic , Neurosurgical Procedures/adverse effects , Cerebral Ventriculitis/etiology , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Cerebrospinal Fluid/microbiology , Risk Factors , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/drug therapy , Cerebral Ventriculitis/diagnosis , Cerebral Ventriculitis/drug therapy , Anti-Bacterial Agents/therapeutic use
3.
Biomédica (Bogotá) ; 39(supl.2): 20-25, ago. 2019. graf
Article in Spanish | LILACS | ID: biblio-1038824

ABSTRACT

Resumen Las feohifomicosis cerebrales son infecciones graves causadas por mohos dematiáceos, entre los cuales Cladophialophora bantiana es una de las especies más comúnmente aislada. Esta tiene tropismo por el sistema nervioso central y frecuentemente produce abscesos cerebrales en pacientes inmunocompetentes; además, en los inmunocomprometidos también puede ocasionar infección diseminada. Pese a la disponibilidad de medicamentos antifúngicos de amplio espectro, a menudo se requiere también la intervención quirúrgica; de todas maneras, la mortalidad es elevada. El diagnóstico debe hacerse interviniendo para tomar la muestra y hacer el cultivo y las pruebas de sensibilidad. Se presenta aquí el caso de un paciente con trasplante renal que presentó un absceso cerebral por C. bantiana, el cual se extrajo mediante resección quirúrgica. El paciente recibió tratamiento con voriconazol, con adecuada respuesta, mejoría y sin secuelas neurológicas.


Abstract Cerebral feohifomycosis are severe infections caused by dematiaceous fungi. Cladophialophora bantiana is one of the most commonly isolated species; it has central nervous system tropism and it often manifests as a brain abscess in immunocompetent patients. In immunocompromised patients, it can lead to brain abscesses and disseminated infections. Despite the availability of broad-spectrum antifungal drugs, it is a must to perform surgical management, in addition to drug therapy. However, mortality is high. The diagnostic approach must be invasive to establish a timely diagnosis and direct treatment based on culture and susceptibility tests. We report a case of brain abscess caused by C. bantiana in an immunosuppressed patient who was treated with surgical resection and voriconazole with an adequate response to therapy and without neurological sequels.


Subject(s)
Humans , Male , Middle Aged , Postoperative Complications/microbiology , Brain Abscess/microbiology , Kidney Transplantation , Saccharomycetales/isolation & purification , Cerebral Phaeohyphomycosis/microbiology , Postoperative Complications/surgery , Postoperative Complications/etiology , Postoperative Complications/drug therapy , Recurrence , Hyperoxaluria, Primary/complications , Hyperoxaluria, Primary/diagnosis , Hyperoxaluria, Primary/genetics , Brain Abscess/surgery , Brain Abscess/etiology , Brain Abscess/drug therapy , Amphotericin B/therapeutic use , Renal Dialysis , Immunocompromised Host , Combined Modality Therapy , Craniotomy , Nephrolithiasis/etiology , Cerebral Phaeohyphomycosis/surgery , Cerebral Phaeohyphomycosis/etiology , Cerebral Phaeohyphomycosis/drug therapy , Graft Rejection/drug therapy , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Antifungal Agents/therapeutic use
4.
J. bras. nefrol ; 41(2): 304-305, Apr.-June 2019. graf
Article in English | LILACS | ID: biblio-1012531

ABSTRACT

Abstract Mineral bone disorder is a common feature of chronic kidney disease. Lion face syndrome is rare complication of severe hyperparathyroidism in end-stage renal disease patients, which has been less commonly reported due to dialysis and medical treatment advances in the last decade. The early recognition of the characteristic facial deformity is crucial to prompt management and prevent severe disfigurement. The authors present a rare case of severe hyperparathyroidism presenting with lion face syndrome and bone fractures.


Resumo O distúrbio mineral e ósseo é uma característica comum da doença renal crônica. A síndrome da face leonina é uma complicação rara do hiperparatireoidismo grave em pacientes com doença renal terminal, que tem sido menos relatada devido aos avanços na diálise e tratamento médico na última década. O reconhecimento precoce da deformidade facial característica é crucial para estimular o tratamento precoce e prevenir a desfiguração severa. Os autores apresentam um caso raro de hiperparatireoidismo grave, apresentando síndrome da face leonina e fraturas ósseas.


Subject(s)
Humans , Female , Adult , Chronic Kidney Disease-Mineral and Bone Disorder/complications , Hyperostosis Frontalis Interna/diagnosis , Hyperostosis Frontalis Interna/etiology , Kidney Failure, Chronic/complications , Postoperative Complications/drug therapy , Bone Density , Hyperostosis Frontalis Interna/surgery , Ergocalciferols/therapeutic use , Calcium/therapeutic use , Parathyroidectomy/adverse effects , Renal Dialysis , Treatment Outcome , Teriparatide/therapeutic use , Fractures, Bone/diagnosis , Bone Density Conservation Agents/therapeutic use , Hypocalcemia/etiology , Hypocalcemia/drug therapy
5.
Rev. bras. anestesiol ; 69(1): 109-112, Jan.-Feb. 2019. graf
Article in English | LILACS | ID: biblio-977412

ABSTRACT

Abstract The report describes a case of peri-operative stroke that presented as diplopia and gait difficulty on 2nd post-operative day after routine orchidopexy under spinal anesthesia in an otherwise healthy young boy. Magnetic resonance imaging of the brain revealed acute infarct in bilateral cerebellar hemispheres, left half of medulla and left thalamus. A diagnosis of acute stroke (infarct) was made and patient was started on oral aspirin 75 mg.day-1, following which his vision started improving after 2 weeks. Possible mechanisms of development of stroke in the peri-operative period are discussed, but, even after extensive investigations, the etiology of infarct may be difficult to determine. Acute infarct after elective non-cardiac, non-neurological surgery is rare; it may not be possible to identify the etiology in all cases. Clinicians must have a high index of suspicion to diagnose such unexpected complications even after routine surgical procedures in order to decrease the morbidity and long term sequelae.


Resumo O presente relato descreve um caso de acidente vascular cerebral perioperatório que resultou em diplopia e dificuldade de marcha no segundo dia após orquidopexia de rotina sob raquianestesia em um jovem, em outros aspectos, saudável. Ressonância magnética cerebral revelou infarto agudo em hemisférios cerebelares bilaterais, metade esquerda do bulbo e tálamo esquerdo. Um diagnóstico de acidente vascular cerebral agudo (infarto) foi feito e o paciente começou a receber tratamento com aspirina oral (75 mg.dia-1), após o qual sua visão começou a melhorar após duas semanas. Possíveis mecanismos de desenvolvimento de acidente vascular cerebral no período perioperatório são discutidos, mas, mesmo após extensas investigações, a etiologia do infarto pode ser difícil de determinar. O infarto agudo após cirurgia eletiva não cardíaca e não neurológica é raro; talvez não seja possível identificar a etiologia em todos os casos. Os médicos devem ter um elevado grau de suspeita para diagnosticar essas complicações inesperadas, mesmo após procedimentos cirúrgicos de rotina, para diminuir a morbidade e as sequelas em longo prazo.


Subject(s)
Humans , Male , Child , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Cerebellum/blood supply , Brain Infarction/diagnosis , Brain Infarction/drug therapy , Orchiopexy , Anesthesia, Spinal
6.
Acta cir. bras ; 34(1): e20190010000009, 2019. tab, graf
Article in English | LILACS | ID: biblio-983686

ABSTRACT

Abstract Purpose: To evaluate the contribution of ursodeoxycholic acid (UDCA) in the first 12 months after Roux-en-Y gastric bypass in the prevention of gallstone formation. Methods: A community-based clinical trial was conducted. A total of 137 patients were included in the study; 69 were treated with UDCA, starting 30 days after the surgery, at a dose of 150 mg twice daily (300 mg/day) over a period of 5 consecutive months (GROUP A), and 68 were control patients (GROUP B). The patients were followed-up, and ultrasonography was performed to determine the presence of gallstones at various times during follow-up. Demographic, anthropometric and comorbid indicators were obtained. The data were subjected to normality tests and evaluated using appropriate tests. Results: Patients did not differ in their baseline characteristics. Of the 69 patients who used UDCA, only one patient developed cholelithiasis (1%), whereas 18 controls (26%) formed gallstones (OR = 24.4, p <0.001). Also, other factors were found not to influence the formation of calculi, such as pre-operative or postoperative hepatic steatosis or diabetes (p = 0.759, 0.468, 0.956). Conclusion: The results demonstrated that patients who did not use UDCA showed a 24.4-fold greater probability of developing cholelithiasis.


Subject(s)
Humans , Male , Female , Adult , Postoperative Complications/prevention & control , Ursodeoxycholic Acid/therapeutic use , Obesity, Morbid/surgery , Cholagogues and Choleretics/therapeutic use , Gastric Bypass/adverse effects , Gallstones/prevention & control , Postoperative Complications/etiology , Postoperative Complications/drug therapy , Postoperative Period , Stomach/surgery , Gallstones/etiology , Gallstones/drug therapy , Comorbidity , Anthropometry , Prospective Studies
7.
J. bras. pneumol ; 44(6): 486-490, Nov.-Dec. 2018. tab
Article in English | LILACS | ID: biblio-984601

ABSTRACT

ABSTRACT Objective: To evaluate the efficacy of mitomycin C (MMC) in the endoscopic treatment of tracheal stenosis. Methods: Patients with laryngotracheal, tracheal, or tracheobronchial stenosis were treated with dilation and topical MMC. The inclusion criteria were as follows: being ineligible for surgery (for medical reasons) at the time of evaluation; membranous stenosis responding well to dilation; and postoperative stenosis at the anastomosis site. Etiology of stenosis and indication for treatment with MMC, as well as site, length, and percentage of stenosis, together with presence of tracheostomy and duration of follow-up, were analyzed. The outcomes evaluated were symptom-free interval ≥ 12 months, number of dilations with topical application of MMC, and complications. Results: Twenty-two patients (15 men and 7 women) were treated between 2003 and 2010. Stenosis was due to endotracheal intubation in 15 patients and surgery in 8. Pure tracheal stenosis was encountered in 13 patients, subglottic stenosis was encountered in 4, tracheobronchial stenosis was encountered in 3, and complex stenosis was encountered in 2. The length of stenosis ranged from 0.5 cm to 2.5 cm, and the percentage of stenosis ranged from 40% to 100%. Nine patients had undergone tracheostomy and had a Montgomery T-tube in situ. Treatment was successful in 14 patients, who remained free of symptoms for at least 12 months. The number of topical applications of MMC ranged from 1 to 5, and complications included fungal infection, keloid scarring, granuloma, and mediastinal emphysema. Conclusions: MMC appears to be effective in the endoscopic treatment of tracheal stenosis.


RESUMO Objetivo: Avaliar a eficácia da mitomicina C (MMC) no tratamento endoscópico de estenose traqueal. Métodos: Pacientes com estenose laringotraqueal, traqueal ou traqueobrônquica foram tratados por meio de dilatação e MMC tópica. Foram empregados os seguintes critérios de inclusão: pacientes inaptos para cirurgia (por motivos médicos) no momento da avaliação; estenose membranosa com boa resposta a dilatação e estenose pós-operatória no local da anastomose. Foram analisadas as seguintes variáveis: etiologia da estenose; indicação de tratamento com MMC; local e extensão da estenose, bem como a porcentagem de estenose; presença de traqueostomia e tempo de seguimento. Os desfechos avaliados foram 12 meses ou mais sem sintomas, número de dilatações com aplicação de MMC tópica e complicações. Resultados: Vinte e dois pacientes (15 homens e 7 mulheres) foram tratados entre 2003 e 2010. As causas da estenose foram intubação endotraqueal em 15 pacientes e cirurgia em 8. A estenose traqueal pura foi observada em 13 pacientes, a subglótica, em 4, a traqueobrônquica, em 3 e a complexa, em 2. A extensão da estenose variou de 0,5 a 2,5 cm, e a porcentagem de estenose variou de 40 a 100%. Nove pacientes haviam sido submetidos a traqueostomia e apresentavam tubo T de Montgomery in situ. O tratamento teve êxito em 14 pacientes, que permaneceram sem sintomas durante pelo menos 12 meses. O número de aplicações de MMC tópica variou de 1 a 5, e as complicações foram infecção fúngica, queloide, granuloma e enfisema mediastinal. Conclusões: A MMC é aparentemente eficaz no tratamento endoscópico de estenose traqueal.


Subject(s)
Humans , Male , Female , Child , Adult , Middle Aged , Young Adult , Postoperative Complications/drug therapy , Tracheal Stenosis/drug therapy , Mitomycin/administration & dosage , Alkylating Agents/administration & dosage , Endoscopy/methods , Postoperative Complications/surgery , Postoperative Complications/etiology , Tracheal Stenosis/surgery , Tracheal Stenosis/etiology , Prospective Studies , Administration, Topical , Treatment Outcome
8.
J. bras. nefrol ; 40(4): 423-427, Out.-Dec. 2018. graf
Article in English | LILACS | ID: biblio-984587

ABSTRACT

Abstract Hemophagocytic lymphohistiocytosis (HLH) is an uncommon and life-threating condition characterized by major immune activation and massive cytokine production by mononuclear inflammatory cells, due to defects in cytotoxic lymphocyte function. It is even more unusual in renal transplant recipients, in which it is often associated with uncontrolled infection. The mortality is high in HLH and differential diagnosis with sepsis is a challenge. The approach and management depend on the underlying trigger and comorbidities. We report a case of a 50-year-old renal transplant female admitted with fever and malaise 3 months post-transplant and presenting anemia, fever, hypertriglyceridemia, high levels of serum ferritin, and positive CMV antigenemia. Urine was positive for decoy cells and BKV-DNA. Graft biopsy showed CMV nephritis. Both blood and urine cultures where positive for E. coli. Hemophagocytosis was confirmed by bone marrow aspiration. Immunosuppression was reduced, and the patient received high-dose intravenous immunoglobulin and dexamethasone, with complete response after 3 weeks. We highlight the importance of early diagnosis and proper management of a rare and serious condition in a renal transplant patient, which can allow a favorable clinical course and improve survival rate.


Resumo A linfohistiocitose hemofagocítica (LHH) é uma condição incomum e potencialmente fatal, caracterizada por importante ativação imunológica e produção maciça de citocinas por células mononucleares inflamatórias, devido a defeitos na função linfocitária citotóxica. É ainda mais incomum em receptores de transplante renal, nos quais está freqüentemente associada a infecções não controladas. A mortalidade da LHH é alta, e o diagnóstico diferencial com sepse é um desafio. A abordagem e o tratamento dependem do gatilho e das comorbidades subjacentes. Relatamos o caso de uma paciente transplantada renal com 50 anos de idade, admitida com febre e mal-estar 3 meses após o transplante, apresentando anemia, febre, hipertrigliceridemia, níveis elevados de ferritina sérica e antigenemia positiva para CMV. A urina mostrou positividade para células decoy e BKV-DNA. A biopsia do enxerto mostrou nefrite por CMV. Ambas as culturas de sangue e urina foram positivas para E. coli. A hemofagocitose foi confirmada pelo aspirado de medula óssea. A imunossupressão foi reduzida e a paciente recebeu altas doses de imunoglobulina intravenosa e dexametasona, com resposta completa após 3 semanas. Destaca-se a importância do diagnóstico precoce e do manejo adequado de uma condição rara e grave em um paciente transplantado renal, o que pode permitir um curso clínico favorável e melhorar a taxa de sobrevida.


Subject(s)
Humans , Female , Middle Aged , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Kidney Transplantation , Lymphohistiocytosis, Hemophagocytic/diagnosis , Lymphohistiocytosis, Hemophagocytic/drug therapy
9.
Rev. bras. cir. plást ; 33(3): 299-304, jul.-set. 2018. ilus
Article in English, Portuguese | LILACS | ID: biblio-965532

ABSTRACT

Introdução: A reconstrução imediata de mama realizada com o expansor de Becker é uma técnica de reconstrução versátil e consolidada na prática médica. Apresentamos uma proposta original com o uso do expansor de Becker associado a um segundo implante mamário. Métodos: Estudo retrospectivo realizado no período de janeiro de 2014 a outubro de 2016 no Hospital A.C. Camargo. A análise dos prontuários das pacientes reconstruídas com Becker 35 avaliou o índice e tipo de complicações e a associação de rádio e quimioterapia e comorbidades das pacientes com 5 casos de associação de implantes. Resultados: 193 reconstruções com Becker em 168 pacientes. Vinte cinco casos com reconstrução bilateral. Idade média de 47 anos e 33% apresentaram comorbidades. Cento e dezenove (62%) pacientes seguiram radioterapia e quimioterapia pós-operatórias. Complicações: seroma em 7 pacientes, hematoma no retalho da mastectomia em 2 pacientes, necrose parcial do retalho da mastectomia em 3 pacientes, necrose/infecção com exposição do expansor em 2 pacientes. O total de complicações foi de 9,5%. Um total de 133 (69%) pacientes foram submetidas a esta segunda etapa cirúrgica para complementação da reconstrução da mama, sendo o expansor de Becker substituído por um implante definitivo. As pacientes com uso de Becker 35 associado a outro implante não apresentaram complicações. Conclusões: A associação do implante-expansor de Becker 35 a um segundo implante mamário foi eficaz em atingir um volume maior nas reconstruções mamárias com baixo índice de complicações.


Introduction: Immediate breast reconstruction performed with the Becker expander is a versatile and accepted technique. We present an original proposal for the use of the Becker expander for a second breast implant. Methods: A retrospective study was performed between January 2014 and October 2016. Medical records were used to evaluate the indications and complications, the use of radio- and chemotherapy, and comorbidities in all patients, including 5 in whom combined implantation was performed. Results: The Becker expander was used for 193 reconstructions in 168 patients, including 25 cases with bilateral reconstructions. The average patient age was 47 years, and 33% had comorbidities. Postoperative radiotherapy and chemotherapy were performed in 119 patients (62%). Complications included seroma in 7 patients, hematoma in the mastectomy flap in 2 patients, partial necrosis of the mastectomy flap in 3 patients, and necrosis/infection with expander exposure in 2 patients. Complications occurred in 9.5% of the cases. A total of 133 (69%) patients underwent a second surgical stage to complement breast reconstruction, with the Becker expander being replaced by a definitive implant. Patients in whom the Becker 35 expander was used in a second breast implant developed no complications. Conclusions: the use of the Becker 35 expander for a second breast implant was effective in achieving greater volume in breast reconstruction with a low rate of complications.


Subject(s)
Humans , Female , Middle Aged , Postoperative Complications/drug therapy , Breast/surgery , Breast/injuries , Mastectomy, Subcutaneous/methods , Mammaplasty/adverse effects , Mammaplasty/rehabilitation , Breast Implants/adverse effects , Plastic Surgery Procedures/methods , Seroma/surgery , Seroma/complications , Seroma/rehabilitation , Postoperative Complications , Radiotherapy , Breast , Mastectomy, Subcutaneous , Mammaplasty , Breast Implants , Plastic Surgery Procedures , Seroma , Drug Therapy
10.
J. bras. nefrol ; 40(2): 143-150, Apr.-June 2018. tab, graf
Article in English | LILACS | ID: biblio-954541

ABSTRACT

ABSTRACT Introduction: Currently, there is no specific immunosuppressive protocol for hepatitis C (HCV)-positive renal transplants recipients. Thus, the aim of this study was to evaluate the conversion effect to everolimus (EVR) on HCV in adult kidney recipients. Method: This is an exploratory single-center, prospective, randomized, open label controlled trial with renal allograft recipients with HCV-positive serology. Participants were randomized for conversion to EVR or maintenance of calcineurin inhibitors. Results: Thirty patients were randomized and 28 were followed-up for 12 months (conversion group, Group 1 =15 and control group, Group 2 =13). RT-PCR HCV levels reported in log values were comparable in both groups and among patients in the same group. The statistical analysis showed no interaction effect between time and group (p value G*M= 0.852), overtime intra-groups (p-value M=0.889) and between group (p-value G=0.286). Group 1 showed a higher incidence of dyslipidemia (p=0.03) and proteinuria events (p=0.01), while no difference was observed in the incidence of anemia (p=0.17), new onset of post-transplant diabetes mellitus (p=1.00) or urinary tract infection (p=0.60). The mean eGFR was similar in both groups. Conclusion: Our study did not show viral load decrease after conversion to EVR with maintenance of antiproliferative therapy.


RESUMO Introdução: Atualmente não há um protocolo imunossupressor específico para os receptores de transplantes renais portadores de hepatite C (HCV). Assim, o objetivo deste estudo foi avaliar o efeito da conversão a Everolimo (EVR) na HCV em receptores adultos de transplantes renais. Método: Trata-se de um estudo unicêntrico, prospectivo, randomizado, exploratório, controlado, aberto em receptores de aloenxertos renais com sorologia positiva para HCV. Os participantes foram randomizados para conversão a EVR ou manutenção dos inibidores da calcineurina. Resultados: Trinta pacientes foram randomizados e 28 foram acompanhados por um período de 12 meses (grupo de conversão, Grupo 1 = 15 e grupo controle, Grupo 2 =13). Níveis de RT-PCR HCV descritos em valores logarítmicos foram comparáveis entre os grupos e entre pacientes em um mesmo grupo. A análise estatística não mostrou efeitos de interação entre tempo e grupo (valor p G*M= 0,852), ao longo do tempo em cada grupo (valor p M=0,889) e entre grupos (valor p G=0,286). O Grupo 1 apresentou uma maior incidência de eventos de dislipidemia (p=0,03) e proteinúria (p=0,01); não houve diferença na incidência de anemia (p=0,17), diabetes mellitus de início pós-transplante (p=1,00) ou infecção do trato urinário (p=0,60). A TFGe média foi semelhante nos dois grupos. Conclusão: Nosso estudo não mostrou redução da carga viral após conversão a EVR com manutenção do tratamento antiproliferativo.


Subject(s)
Humans , Male , Female , Adult , Postoperative Complications/drug therapy , Kidney Transplantation , Hepatitis C, Chronic/drug therapy , Calcineurin Inhibitors/therapeutic use , Everolimus/therapeutic use , Immunosuppressive Agents/therapeutic use , Postoperative Complications/virology , Viremia/drug therapy , Prospective Studies
11.
Rev. bras. cir. plást ; 33(2): 211-216, abr.-jun. 2018. ilus, tab
Article in English, Portuguese | LILACS | ID: biblio-909407

ABSTRACT

INTRODUÇÃO: O objetivo é avaliar a presença de equimose com 7 e 15 dias após osteotomia nasal lateral interna e externa na rinoplastia aberta. Métodos: Análise prospectiva, dos pacientes submetidos à rinoplastia aberta, com osteotomia nasal lateral com total de 15 pacientes. Os pacientes foram alocados em dois grupos. Aqueles submetidos à osteotomia nasal lateral externa formaram o grupo A (n = 6) e os submetidos à osteotomia interna, o grupo B (n = 9). Foram avaliados com 7 e 15 dias de pós-operatório e registrada a presença ou ausência de equimose. Resultados: Dentro do grupo A evidenciamos no 7º dia de pós-operatório 3 (50%) pacientes com equimose e 3 (50%) sem alteração na tonalidade da pele. Com 15 dias de pós-operatório, o mesmo grupo apresentava 2 (25%) pacientes com equimose e 4 (75%) sem alteração. Já no grupo B foram identificados no 7º dia após o procedimento 3 (33,4%) pacientes com presença de equimose e 6 (66,6%) sem alteração. O mesmo grupo após 15 dias do procedimento apresentou 1 (11,1%) paciente com equimose e 8 (88,9%) sem alteração. Conclusão: Apesar da fratura interna apresentar menor incidência de equimose no sétimo e décimo quinto dias de pós-operatório, não houve relevância estatística na comparação entre as técnicas.


Introduction: The objective is to evaluate the presence of ecchymosis 7 and 15 days after internal and external lateral nasal osteotomy in open rhinoplasty. Methods: A prospective evaluation of 15 patients who underwent open rhinoplasty with lateral nasal osteotomy was conducted. The patients were allocated into two groups. Those who underwent external lateral nasal osteotomy were included in group A (n = 6), while those who underwent internal osteotomy were included in group B (n = 9). The patients were evaluated on postoperative days 7 and 15, and the presence or absence of ecchymosis was recorded. Results: In group A, we observed that on postoperative day 7, 3 patients (50%) had ecchymosis and 3 (50%) showed no changes in skin color. On postoperative day 15, the same group had 2 patients (25%) with ecchymosis and 4 (75%) without changes. On the other hand, in group B, 3 patients (33.4%) had ecchymosis and 6 (66.6%) showed no changes on postoperative day 7. In the same group, 1 patient (11.1%) had ecchymosis and 8 (88.9%) showed no changes 15 days after surgery. Conclusion: Despite the lower incidence of ecchymosis in internal fractures on postoperative days 7 and 15, no statistical significance was observed between the two techniques.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , History, 21st Century , Osteotomy , Postoperative Complications , Rhinoplasty , Nose , Prospective Studies , Ecchymosis , Osteotomy/adverse effects , Osteotomy/methods , Osteotomy/rehabilitation , Postoperative Complications/drug therapy , Rhinoplasty/adverse effects , Rhinoplasty/methods , Rhinoplasty/rehabilitation , Nose/surgery , Ecchymosis/surgery , Ecchymosis/rehabilitation
12.
Rev. chil. pediatr ; 89(2): 241-245, abr. 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-900093

ABSTRACT

INTRODUCCIÓN: Las infecciones por Aspergillus spp son la principal infección micótica por hongos en pacientes con trasplante hepático, con una mortalidad reportada de hasta un 90% de los casos. En los pacientes trasplantados de hígado se espera que hasta un 50% desarrollen un episodio infeccioso en sus primeros meses postrasplante, de los cuales un 10% se asocian con agentes oportunistas. OBJETIVO: Describir el diagnóstico y manejo de un episodio de Aspergilosis Pulmonar Invasora (API) en una paciente con un trasplante hepático CASO CLÍNICO: Paciente de 11 meses de vida, con trasplante hepático secundario a atresia de vías biliares. En el periodo post-trasplante inmediato evolucionó con una neumonía grave asociada a ventilación mecánica. El lavado broncoalveolar presentó niveles altos de galactomanano y cultivo positivo para Aspergillus fumigatus, diagnosticándose una API. Este episodio se trató con un esquema de antifúngico con un resultado clínico favorable. CONCLUSIÓN: La API es una infección oportunista en pacientes con trasplante hepático, que debe ser sospechada en este grupo de pacientes, ya que el diagnóstico y tratamiento oportuno impacta directamente en la resolución de la infección por Aspergillus fumigatus.


INTRODUCTION: Mycotic infections due to Aspergillus spp, are the main mycotic associated infections in liver transplant patients, with mortality rates up to 90% of the cases. Almost 50% of patients will de velop an infection during the first months after transplantation, of which 10% are associated with op portunistic agents. OBJECTIVE: To describe the diagnosis and management of an Invasive Pulmonary Aspergillosis (IPA) episode in a liver transplant patient. CASE-REPORT: 11-months-old patient with liver transplant due to a biliary atresia who developed severe pneumonia associated with mechanical ventilation. The bronchoalveolar lavage showed high levels of galactomannan and positive culture for Aspergillus fumigatus leading to an IPA diagnosis. This episode was treated with antifungal with a favorable outcome. CONCLUSION: The IPA is an opportunistic infection in liver transplant patients, with high mortality rates, that must be suspected in this group of patients since an early diagnosis and treatment reduce mortality.


Subject(s)
Humans , Female , Infant , Postoperative Complications/diagnosis , Liver Transplantation , Invasive Pulmonary Aspergillosis/diagnosis , Postoperative Complications/drug therapy , Invasive Pulmonary Aspergillosis/etiology , Invasive Pulmonary Aspergillosis/drug therapy , Antifungal Agents/therapeutic use
13.
Rev. cuba. oftalmol ; 31(1): 82-89, ene.-mar. 2018.
Article in Spanish | LILACS | ID: biblio-960633

ABSTRACT

El edema quístico macular es, actualmente, una de las complicaciones posoperatorias más prevalentes después de la cirugía de cataratas. En no pocos casos acarrea una disminución en la agudeza visual posquirúrgica de los pacientes. Por la heterogeneidad de criterios diagnósticos, su incidencia ha sido reportada entre el 1 y el 30 por ciento. Con el objetivo de mostrar los resultados del uso de la dorzolamida en el edema quístico macular poscirugía de catarata se realizó la presente revisión de la literatura, mediante búsquedas en diferentes publicaciones relacionadas con la especialidad, en la que fueron utilizadas bases de datos de revistas líderes de Oftalmología de los últimos 10 años. Como la complicación posoperatoria más frecuente de la cirugía de catarata, puede traducirse con pérdida de la visión posoperatoria y cobra importancia el abordaje de aspectos relacionados con el tratamiento, específicamente los resultados de investigaciones que promueven en la actualidad el uso de inhibidores de la anhidrasa carbónica tópicos. En tal sentido, se muestra que la dorzolamida ha cobrado importancia como una opción de tratamiento, con resultados tangibles y pocos efectos adversos en comparación con el empleo sistémico de este grupo de medicamentos(AU)


Macular cystic edema is one of the most prevalent postoperative complications after cataract surgery, leading in many cases to a decrease of postsurgical visual acuity in the patients. Due to the heterogeneity of diagnostic criteria, its incidence has been reported between 1 percent and 30 percent. With the objetive to show the results of the use of dorzolamide in the macular cystic edema after cataract surgery, we was carried out through searches in different publications related to the specialty, using data from leading ophthalmology journals, from the last 10 years. As the most frequent postoperative complication of cataract surgery, that can be translated with loss of postoperative vision, it is important to address aspects related to treatment and specifically the results of research that currently promote the use of topical carbonic anhydrase inhibitors. In this regard, dorzolamide has become important as a treatment option, with tangible results and few adverse effects compared with the systemic use of this group of drugs(AU)


Subject(s)
Humans , Postoperative Complications/drug therapy , Review Literature as Topic , Macular Edema/drug therapy , Databases, Bibliographic/statistics & numerical data
14.
J. bras. nefrol ; 40(1): 95-97, Jan.-Mar. 2018. graf
Article in English | LILACS | ID: biblio-893819

ABSTRACT

Abstract Histoplasmosis is a fungus infection that mainly affects immunosuppressed patients. The authors present a case of a kidney transplant recipient who developed sepsis-like histoplasmosis, na atypical but severe manifestation of the disease. The fungus was found in blood and in a skin biopsy, and the treatment with liposomal amphotericin resulted in hepatotoxicity.


Resumo Histoplasmose é uma infecção fúngica que afeta principalmente pacientes imunossuprimidos. Os autores apresentam um caso de uma receptora de transplante de rim que desenvolveu histoplasmose disseminada, uma manifestação atípica, mas grave da doença. O fungo foi encontrado no sangue e na biópsia cutânea, e o tratamento com anfotericina lipossomal resultou em hepatotoxicidade.


Subject(s)
Humans , Female , Middle Aged , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Kidney Transplantation , Sepsis/diagnosis , Histoplasmosis/diagnosis , Histoplasmosis/drug therapy , Fatal Outcome , Sepsis/drug therapy
15.
Rev. peru. med. exp. salud publica ; 35(1): 145-149, ene.-mar. 2018. ilus
Article in Spanish | LILACS | ID: biblio-1020771

ABSTRACT

La infección por citomegalovirus postrasplante cardiaco es una condición médica recurrente. Su frecuencia se incrementa cuando los donantes poseen serología positiva y los receptores presentan serología negativa para el virus. En la población pediátrica, la enfermedad solo se desarrolla en un porcentaje pequeño y raramente presentan resistencia al tratamiento convencional con ganciclovir y valganciclovir. Presentamos el primer reporte de caso pediátrico de enfermedad por citomegalovirus resistente a ganciclovir y valganciclovir postrasplante cardiaco en un hospital público peruano, con una presentación inusual. La resistencia a estos fármacos fue evidente luego de 277 días de evolución de la enfermedad, ante la no remisión de la sintomatología y la persistencia de una carga viral elevada. La posterior administración de foscarnet condujo a una mejora clínica y de laboratorio, hasta la remisión de la enfermedad.


Cytomegalovirus infection after a heart transplant is a recurrent medical condition. Its frequency increases when the donors are serum-positive, and the recipients are serum-negative to this virus. In the pediatric population, the infection only develops in a small percentage and the patients rarely present resistance to conventional treatment with ganciclovir and valganciclovir. We presented the first report of a pediatric case of the cytomegalovirus infection resistant to ganciclovir and valganciclovir after a heart transplant in a Peruvian public hospital with an unusual presentation. The resistance to these drugs was evident after 277 days of evolution of the disease considering the non-remission of the symptomatology and the persistence of an elevated viral load. The administration of foscarnet led to a clinical and laboratory improvement until remission of the disease.


Subject(s)
Child , Humans , Male , Antiviral Agents/therapeutic use , Postoperative Complications/drug therapy , Postoperative Complications/virology , Ganciclovir/therapeutic use , Heart Transplantation , Cytomegalovirus Infections/drug therapy , Drug Resistance, Viral
16.
Article in Spanish | LILACS | ID: biblio-990879

ABSTRACT

RESUMEN La operación cesárea tiene una alta incidencia en nuestro país. La analgesia post operatoria que recibe la madre es un factor importante y debe ser de calidad con enfoque multimodal. Se han utilizado diversas estrategias terapéuticas para disminuir el dolor post quirúrgico. Los opioides intratecales han sido útiles junto con algunos fármacos coadyuvantes. La analgesia endovenosa con antiinflamatorios no esteroidales y acetaminofeno o en combinación es parte del uso actual y reduce los requerimientos de morfina de rescate endovenosa. Realizamos una revisión de cada una de las técnicas mencionadas con anterioridad con relación a la calidad de la analgesia posterior a operación cesárea haciendo énfasis en el uso de drogas intratecales y medicamentos endovenosos. Discutimos además el verdadero rol del uso de anestésicos locales tanto en infusión continua como en infiltración de herida operatoria, así como en bloqueos de pared abdominal; para al término concluir en una estrategia de manejo adecuada para la operación cesárea. Finalmente, el dolor crónico post operación cesárea presenta una alta incidencia en pacientes que recibieron una analgesia deficiente post cirugía, constituyendo a menudo, un problema importante para la paciente y el equipo quirúrgico tratante.


ABSTRACT Cesarean section has a high incidence in our country. Postoperative analgesia has always been done with a multimodal approach trying to achieve quality and diminishing secondary effects. The strategies that have been used to reduce post-surgical pain include intrathecal opioids and intravenous analgesia with non-steroidal antiinflammatories drugs and acetaminophen, which finally reduces the requirements of rescue morphine. We carried out a review of the drugs mentioned before, and we discussed the use of local anesthetics used in continuous infusion, surgical wound infiltration as well as in abdominal wall nerve block. We emphasized in the use of intrathecal drugs such as opioids and intravenous drugs as supplementary, trying to define an appropriate management strategy for post-surgical pain after cesarean section. Finally, when patients receive an inadequate analgesia scheme after surgery, including cesarean section, they may develop chronic pain, establishing an important problem for the patient herself, as well as, for the surgical team.


Subject(s)
Humans , Female , Pain, Postoperative , Cesarean Section , Pain Management/methods , Analgesia/methods , Analgesics , Postoperative Complications/drug therapy
17.
Rev. chil. anest ; 47(3): 224-228, 2018. ilus
Article in Spanish | LILACS | ID: biblio-1451166

ABSTRACT

Myotonic dystrophy is an uncommon disease, characterised by disorders of the muscle membrane. Its clinical manifestations are muscle weakness, difficulty at initiating movements and delayed muscle relaxation. Carriers of this disease are very sensitive to anaesthetic drugs. Residual neuromuscular blockade is common among these patients, leaving them at risk of various postoperative complications. Proper neuromuscular blockade reversal is therefore crucial. We report the case of an 18-year-old male with myotonic dystrophy type I (Steinert's disease), who was admitted for a complicated hydatid cyst. He required a laparotomy, which was done under general anesthesia with no intraoperative incidents. He was extubated at the end of the procedure, with 94% response at the train-of-four (TOF) and adequate spontaneous ventilation. No reversal for neuromuscular blockade was given. The patient evolved favourably during the postoperative phase. However, in the later postoperatory period the patient presented severe respiratory complications. Proper anaesthetic management of these patients, as described in the literature, includes the use of non-depolarising muscle relaxants, monitoring of muscle relaxation and reversal of neuromuscular blockade. The combination of rocuronium and sugammadex appears to convey the optimum reversal required for these cases.


Las distrofias miotónicas son enfermedades poco comunes, caracterizadas por trastornos a nivel de la membrana muscular. Clínicamente se manifiestan por debilidad muscular progresiva, dificultad al iniciar movimientos y retardo en la relajación muscular. Los portadores de este grupo de enfermedades tienen una marcada sensibilidad a los fármacos anestésicos. Es habitual que presenten bloqueo neuromuscular residual, arriesgándose a sufrir diversas complicaciones postoperatorias. Por ello, es importante realizar una reversión adecuada de la relajación muscular en estos pacientes. Presentamos el caso de un paciente masculino de 18 años, con distrofia miotónica de Steinert tipo I, que ingresa para laparotomía por quiste hidatídico hepático complicado. Recibió anestesia general sin incidentes. Es extubado con una respuesta al tren-de-cuatro (TOF) de 94% y ventilación espontánea adecuada. No se realiza reversión del bloqueo neuromuscular y evoluciona favorablemente en el postoperatorio inmediato. Sin embargo, en el período postoperatorio tardío, presenta complicaciones respiratorias severas. El adecuado manejo de estos pacientes, según lo recomendado en la literatura, requiere el uso de relajantes no-depolarizantes, monitorización y reversión del bloqueo neuromuscular, siendo probablemente la combinación de rocuronio y sugammadex, la más adecuada para estos fines.


Subject(s)
Humans , Male , Adolescent , Postoperative Complications/drug therapy , Respiratory Tract Diseases/chemically induced , Myotonic Dystrophy/surgery , Neuromuscular Blocking Agents/adverse effects , Postoperative Complications/chemically induced , Sugammadex/therapeutic use , Rocuronium/therapeutic use , Neuromuscular Depolarizing Agents/therapeutic use
18.
J. bras. nefrol ; 39(3): 341-344, July-Sept. 2017. graf
Article in English | LILACS | ID: biblio-893776

ABSTRACT

Abstract Granulicatella and Abiotrophia are genera of fastidious Gram-positive cocci commensal of the oral, genitourinary, and intestinal flora. We report the first case of infective endocarditis caused by Granulicatella sp. in a kidney transplant recipient. A 67-year-old male kidney transplant recipient was admitted to the hospital for investigation of fever, abdominal pain, and diarrhea. On physical examination, he was dehydrated. Laboratory tests identified impaired renal function (creatinine level of 15.5 mg/dl; reference, 3.0 mg/dl), metabolic acidosis, and electrolyte disturbances. Cryptosporidium sp. was identified as the cause of the diarrhea, and the infection was treated with nitazoxanide. On admission, cultures of blood, urine, and stool samples were negative. Echocardiography results were normal. Despite the antimicrobial treatment, the fever persisted. A transthoracic echocardiogram revealed infective endocarditis of the mitral valve, and Granulicatella spp. were isolated in blood cultures. Although the patient was treated with penicillin and amikacin, he evolved to septic shock of pulmonary origin and died. Infective endocarditis caused by Granulicatella sp. should be suspected in cases of culture-negative endocarditis.


Resumo Granulicatella e Abiotrophia são gêneros de cocos gram-positivos fastidiosos comensais das floras oral, genitourinária e intestinal. Relatamos o primeiro caso de endocardite infecciosa por Granulicatella sp. em paciente transplantado renal. Paciente do sexo masculino, 67 anos, foi admitido no hospital para investigação de febre, dor abdominal e diarreia. Ao exame físico encontrava-se desidratado. Exames laboratoriais identificaram piora de função renal (creatinina: 15,5mg/dL - níveis basais: 3mg/dL), acidose metabólica e distúrbios eletrolíticos. Cryptosporidium sp foi identificado como causa da diarréia e tal germe foi tratado com nitazoxanida. À admissão, hemoculturas, urocultura e coprocultura negativas além de ecocardiograma normal. A despeito do tratamento antimicrobiano, paciente persistiu febril. Um ecocardiograma transtorácico posterior foi realizado, revelando endocardite em válvula mitral, sendo então identificada em hemocultura Granulicatella sp. Apesar do tratamento com penicilina e amicacina, o paciente evoluiu com quadro de choque séptico de foco pulmonar e óbito. Endocardite infecciosa por Granulicatela sp. deve ser suspeitada em casos de endocardite com hemoculturas negativas.


Subject(s)
Humans , Male , Aged , Kidney Transplantation , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/drug therapy , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/drug therapy , Carnobacteriaceae , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Fatal Outcome
SELECTION OF CITATIONS
SEARCH DETAIL